| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Dividende/HV | Profil | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Vergleich | Insidertrades | Knock-outs | myHome |
| Orderbuch | Realtime Stuttgart | RSS Feed | Analyse | im Forum | Fonds | Senden |
| Historisch | Realtime Push | myNews neu | IR-Daten | Anleihen | handeln | |
| Analyst | Buy | Hold | Sell | Kursziel* | Abstand | Datum |
|---|---|---|---|---|---|---|
| RBC Capital Markets | - | - | 21.05.12 | |||
| Banc of America Securities-Merrill Lynch | 80,00$ | +22,46% | 30.04.12 | |||
| Barclays Capital | 86,00$ | +31,64% | 03.04.12 | |||
| Stifel, Nicolaus & Co., Inc. | 87,00$ | +33,17% | 16.03.12 | |||
| Der Aktionär | 70,00€ | - | 09.02.12 | |||
| UBS AG | 88,00$ | +34,70% | 27.01.12 | |||
| Sanford C. Bernstein and Co., Inc. | 90,00$ | +37,76% | 04.01.12 | |||
| Jefferies & Company Inc. | 72,00$ | +10,21% | 15.12.11 | |||
| Citigroup Corp. | 76,00$ | +16,33% | 07.12.11 |
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 3 | 1 | 1 | 60,00 $ | -0,86% |
| AstraZeneca plc | 2 | 4 | 5 | 28,19 £ | +8,76% |
| Bayer | 15 | 12 | 0 | 61,22 € | +25,40% |
| Bristol-Myers Squibb Co. | 2 | 1 | 0 | 35,33 $ | +6,00% |
| Celgene Corp. | 8 | 1 | 0 | 82,71 $ | +26,60% |
| GlaxoSmithKline plc (GSK) | 5 | 8 | 1 | 15,31 £ | +8,20% |
| Johnson & Johnson | 5 | 4 | 0 | 71,80 $ | +16,22% |
| Merck Co. | 2 | 3 | 0 | 38,50 $ | +3,55% |
| Novartis AG | 10 | 8 | 1 | 56,60 | +13,27% |
| Pfizer Inc. | 7 | 4 | 1 | 23,75 $ | +9,75% |